Latest news
Loading news…
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
2
1 exits
Monthly Visits
Available in Pro Contacts
546
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Investor Activity
- Investments
- 2
- Lead investments
- 1
- Portfolio orgs
- 2
- Exits
- 1
- Exits via IPO
- 1
Company Info
- Org types
- company, investor
- HQ
- Cambridge, Massachusetts, United States
- Diversity spotlight
- Women Founded
Investments by Intellia Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Intellia Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Intellia Therapeutics
President and Chief Executive Officer
Founder
Co-Founder
Founder & Advisor
Senior Vice President Technical Operations and Quality
Senior Director Alliance Management
EVP, CFO, and Treasurer
Executive Vice President and Chief Scientific Officer
Chief Medical Officer
546
professional contacts at Intellia Therapeutics
Contact execs at Intellia Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Intellia Therapeutics
Loading news…
FAQs about Intellia Therapeutics
People who checked this page also checked these
Sectors Intellia Therapeutics invests & acquires in
Browse the full Acquirezy directory.